TREM2 and neoplasm: Simultaneously, administration of anti-TREM-2 mAb in the lung cancer-bearing mice 7 days after tumor transplantation, depleting in vivo TREM-2, also, could not prolong the survival of tumor-bearing mice (Figure 8C).